Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Glooko provides an integrated digital health platform used by over 4.4 million people worldwide to manage diabetes and related chronic conditions. The system aggregates data from more than 200 medical devices—including glucose monitors, insulin pumps, CGMs—and delivers actionable insights to patients and providers. Clinical studies show measurable improvements in glycemic control within three months of use. The company also supports remote patient monitoring solutions tailored to specific markets like France (“GlookoXT”), integrates with major EHRs such as Epic for seamless workflow adoption, and offers FDA-compliant platforms for connected clinical trials in partnership with leading pharma companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Glooko.